| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 10, 331-341, Copyright © 1996 by Endocrine Society
ARTICLES |
ME Rothenberg, CD Eilertson, K Klein, RB Mackin and BD Noe
Department of Anatomy and Cell Biology, Emory University, Atlanta, Georgia 30322, USA.
To further examine the physiological roles of the neuroendocrine prohormone convertases (PCs) in proglucagon processing, alpha TC1-6 cells were transiently transfected with PC1/3 and PC2 expression vectors containing either antisense or sense encoding cDNAs. PC1/3- and PC2-directed RIAs were used to determine that the PC1/3 antisense transfections lowered endogenous levels of PC1/3 by 40 +/- 7.9% but did not alter the levels of PC2. The PC2 antisense transfections decreased the endogenous levels of PC2 by 91 +/- 11.7% without affecting the levels of PC1/3. To quantitate the levels of proglucagon and proglucagon-derived products, transfected cells were metabolically labeled with [3H]tryptophan, and extracts were chromatographed by reversed-phase HPLC. Recovered peptides were then subjected to peptide mapping analyses, allowing precise quantification of 3H-radioactivity incorporated into proglucagon and its cleavage products. Product- precursor ratios were determined, and percent change in the proportion of products generated in antisense-transfected vs. sense-transfected cells was calculated. The decrease in PC1/3 after antisense treatment significantly reduced the amounts of glicentin produced and partially reduced the levels of all other proglucagon cleavage products. PC2 antisense treatment significantly reduced the levels of glicentin and 9K glucagon generated but had no significant effect on the remainder of the proglucagon-derived peptides. These results suggest the existence of redundant mechanisms that ensure the production of each of the intermediate and product peptides derived from proglucagon. PC1/3 is potentially an important enzyme in the processing of most proglucagon- derived peptides, whereas PC2-processing activity appears to predominate at only two of the four potential cleavage sites.
This article has been cited by other articles:
![]() |
A. Dey, G. M. Lipkind, Y. Rouille, C. Norrbom, J. Stein, C. Zhang, R. Carroll, and D. F. Steiner Significance of Prohormone Convertase 2, PC2, Mediated Initial Cleavage at the Proglucagon Interdomain Site, Lys70-Arg71, to Generate Glucagon Endocrinology, February 1, 2005; 146(2): 713 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ugleholdt, X. Zhu, C. F. Deacon, C. Orskov, D. F. Steiner, and J. J. Holst Impaired Intestinal Proglucagon Processing in Mice Lacking Prohormone Convertase 1 Endocrinology, March 1, 2004; 145(3): 1349 - 1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lovshin, B. Yusta, I. Iliopoulos, A. Migirdicyan, L. Dableh, P. L. Brubaker, and D. J. Drucker Ontogeny of the Glucagon-Like Peptide-2 Receptor Axis in the Developing Rat Intestine Endocrinology, November 1, 2000; 141(11): 4194 - 4201. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Kieffer and J. Francis Habener The Glucagon-Like Peptides Endocr. Rev., December 1, 1999; 20(6): 876 - 913. [Abstract] [Full Text] |
||||
![]() |
A. B. Damholt, A. M. J. Buchan, J. J. Holst, and H. Kofod Proglucagon Processing Profile in Canine L Cells Expressing Endogenous Prohormone Convertase 1/3 and Prohormone Convertase 2 Endocrinology, October 1, 1999; 140(10): 4800 - 4808. [Abstract] [Full Text] |
||||
![]() |
A. Viale, C. Ortola, G. Hervieu, M. Furuta, P. Barbero, D. F. Steiner, N. G. Seidah, and J.-L. Nahon Cellular Localization and Role of Prohormone Convertases in the Processing of Pro-melanin Concentrating Hormone in Mammals J. Biol. Chem., March 5, 1999; 274(10): 6536 - 6545. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dhanvantari and P. L. Brubaker Proglucagon Processing in an Islet Cell Line: Effects of PC1 Overexpression and PC2 Depletion Endocrinology, April 1, 1998; 139(4): 1630 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Furuta, H. Yano, A. Zhou, Y. Rouille, J. J. Holst, R. Carroll, M. Ravazzola, L. Orci, H. Furuta, and D. F. Steiner Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2 PNAS, June 24, 1997; 94(13): 6646 - 6651. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Furuta, A. Zhou, G. Webb, R. Carroll, M. Ravazzola, L. Orci, and D. F. Steiner Severe Defect in Proglucagon Processing in Islet A-cells of Prohormone Convertase 2 Null Mice J. Biol. Chem., July 13, 2001; 276(29): 27197 - 27202. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |